Filter
1780
Filtered Results: 1780
Text search:
World
Health
Organization
WHO
and
World
Intellectual
Property
Organization
Featured
Recommendations
217
New Publications
382
Language
Document type
No document type
654
Studies & Reports
387
Guidelines
344
Manuals
193
Strategic & Response Plan
110
Training Material
51
Fact sheets
27
Situation Updates
7
Resource Platforms
4
Infographics
3
Countries / Regions
Global
143
India
34
Africa
27
South–East Asia Region
27
Western and Central Europe
27
Ukraine
26
Kenya
25
Uganda
23
Ethiopia
21
South Africa
20
Nepal
17
Ghana
16
Eastern Europe and Central Asia
16
Nigeria
14
Asia
14
Myanmar / Burma
13
Sierra Leone
12
West and Central Africa
12
East and Southern Africa
12
Bangladesh
12
Zambia
12
Syria
11
Malawi
11
Indonesia
11
Liberia
11
Cambodia
10
Tanzania
10
Rwanda
9
Middle East and North Africa
9
Western Pacific Region
8
Yemen
7
South Sudan
7
Lesotho
6
Afghanistan
6
Philippines
6
Eastern Europe
6
Thailand
5
Cameroon
5
Zimbabwe
5
Guinea
5
Mozambique
5
Latin America and the Carribbean
5
Congo, Democratic Republic of
5
Somalia
5
Pakistan
5
Haiti
4
Vietnam
4
Russia
4
Sudan
4
North Macedonia
3
Tajikistan
3
Kazakhstan
3
Iran
3
Laos
3
Burkina Faso
3
Germany
3
Lebanon
3
Colombia
2
Timor Leste/ East Timor
2
China
2
Kyrgyzstan
2
Peru
2
Venezuela
2
Lithuania
2
Jordan
2
Saudi Arabia
2
Côte d’Ivoire / Ivory Coast
2
Sri Lanka
2
Djibouti
2
Palestine
2
Georgia
2
Angola
2
Botswana
2
Iraq
2
Ecuador
2
North Korea
1
Mexico
1
Serbia
1
Turkey
1
Chile
1
Albania
1
Canada
1
Senegal
1
Estonia
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
USA
1
Paraguay
1
Japan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Namibia
1
Egypt
1
Greece
1
Mali
1
Chad
1
Libya
1
Bhutan
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
354
Clinical Guidelines
225
Public Health
167
Women & Child Health
131
Key Resources
110
Capacity Building
53
Pharmacy & Technologies
43
Toolboxes
Mental Health
179
COVID-19
148
HIV
140
Disability
140
TB
98
Caregiver
88
Planetary Health
85
AMR
70
Rapid Response
65
NTDs
63
Global Health Education
56
Pharmacy
42
Conflict
42
NCDs
41
Refugee
20
Health Financing Toolbox
20
Ebola
17
Specific Hazards
10
Natural Hazards
9
Social Ethics
8
Polio
6
Zika
4
Cholera
3
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution...
1 March 2021 This roadmap aims to define the key questions users should consider to assess indoor ventilation and the major steps needed to reach recommended ventilation levels or simply improve indoor air quality (IAQ) in order to reduce the risk of spread of COVID-19.
It also includes recommendat...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
Diabetes mellitus, commonly known as diabetes, is a group of metabolic disorders characterized by the presence of hyperglycaemia in the absence of treatment. The heterogeneous aetiopathology includes defects in insulin secretion, insulin action, or both. The long-term specific complications of diabe...
Overview: Risk communication and community engagement are essential for any disease outbreak response. This is particularly critical during outbreaks of Ebola which may create fear in the public and frontline responders alike due to severe presentation of symptoms, misunderstanding of the causes of ...
Disinfection of drinking-water supplies has been one of the most significant public health advancements of the last century with respect to reducing waterborne disease.
Although chlorine has been used as the disinfectant of choice for public drinking-water supplies for the past century, a numbe...
Although chlorine has been used as the disinfectant of choice for public drinking-water supplies for the past century, a numbe...
This guide is a revised edition to the previous version published in 2017.
This updated publication provides programme managers with a user-friendly tool that can: (i) analyse and draw conclusions from historic dengue datasets; (ii) identify appropriate alarm indicators that can predict forthcoming...
Toolkit
HIV Treatment and Care
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
July 2019
Policy brief
HIV Treatment
Guide for clinical case management and infection prevention and control during ameasles outbreak. This guide has been developed to reduce the high morbidity and mortality seen in some of the current outbreaks of measles. This short guide outlines practical clinical care interventions and is derived ...
The Leprosy Programme and Transmission Assessment (LPTA) is an activity that is carried out by internal teams towards the end of Phase 1 (see Leprosy Elimination Framework in the Annex) when a subnational jurisdiction (typically second-tier) reaches the milestone for interruption of transmission, i....
The Leprosy Programme and Transmission Assessment (LPTA) is an activity that is carried out by internal teams towards the end of Phase 1 (see Leprosy Elimination Framework in the Annex) when a subnational jurisdiction (typically second-tier) reaches the milestone for interruption of transmission, i....
